18 January 2024
Ropes & Gray Advises HilleVax in Exclusive License Agreement to Acquire Norovirus Vaccine Rights
Advising firms
Deal team
2 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Geoffrey Lin Lead | Ropes & Gray | Partner | IP transactions | Not stated |
| Dan Freshman | Ropes & Gray | Associate | Not stated | Not stated |
Stated terms
- Stated value
- USD 15m ($15 million upfront)
- What the figure measures
- Total transaction value
- Client
- HilleVax, Inc.Buy-side
- Counterparties
- Chengdu Kanghua Biological Products Co., Ltd. (Kangh) (Sell-side)